CBD LEO-HB® uses

Unraveling the Truth to CBD Claims: A Journey Through Its Uses Backed by Science

Welcome, to the intriguing realm of Cannabidiol, better known as CBD! In a world buzzing with wellness trends, Cannabidiol, or CBD, has emerged as a frontrunner, promising a plethora of health benefits. But are these benefits fact or fiction? We’ll embark on an enlightening journey through the uses and health advantages of CBD, exploring its various claims to fame that are backed by notable clinical trials.

CBD 101 – Breaking the Stigma

Before we dive into the nitty-gritty of clinical trials, let’s demystify CBD. Derived from the cannabis plant, CBD is the non-psychoactive sibling of THC, the infamous party crasher responsible for marijuana’s euphoric effects. CBD, on the other hand, is the cool, calm, and collected member of the family, offering a myriad of potential health benefits without the mind-altering buzz.

CBD LEO-HB® logo

CBD LEO-HB®  is an instantly Cold Water Dispersible and Soluble form of CBD. Our Technology transforms insoluble CBD into a highly bioavailable CBD that can be used in drinks, powders, and all variety of novel food formats. 

Anxiety and Stress – CBD to the Rescue

Picture a serene landscape where anxiety and stress are mere whispers in the wind, no longer having a hold on our thoughts and emotions. Rest assured that It’s a fact that many clinical trials have shown that CBD can be a knight in shining armor for those battling anxiety. Here are just a few examples:

 Clinical Trial: “Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients”

Published in: Neuropsychopharmacology (2011)

In this groundbreaking trial, researchers investigated the anxiolytic (anxiety-reducing) effects of CBD in social phobia patients. The conclusion revealed that a single dose of CBD significantly reduced anxiety during a public speaking simulation, suggesting its potential as a therapeutic agent for anxiety disorders.

Clinical Trial: “Cannabidiol as a Potential Treatment for Anxiety Disorders”

Published in: Neurotherapeutics (2015)

This comprehensive review of existing preclinical and clinical studies explored the role of CBD in treating various anxiety disorders. The researchers concluded that CBD shows promise as a potential treatment for multiple anxiety disorders, paving the way for further exploration in clinical settings:

“Preclinical evidence conclusively demonstrates CBD’s efficacy in reducing anxiety behaviors relevant to multiple disorders, including PTSD, GAD, PD, OCD, and SAD, with a notable lack of anxiogenic effects.”

Woman Sleeping

Sleep Disorders – CBD’s Lullaby

As the moon rises and the world goes silent, the struggle for a good night’s sleep begins for many. Fear not, dear readers, for it is a fact that CBD may hold the key to peaceful slumber. A clinical trial published in The Permanente Journal in 2019 found that CBD supplementation improved sleep scores in individuals with anxiety. So, if counting sheep isn’t cutting it, perhaps it’s time to count on CBD.

 Clinical Trial: “Cannabidiol in Anxiety and Sleep: A Large Case Series”

Published in: The Permanente Journal (2019)

Focusing on anxiety and sleep, this trial presented a large case series exploring the impact of CBD on both conditions. The results showed that CBD not only reduced anxiety scores but also improved sleep in a majority of the subjects, suggesting a dual benefit for those struggling with both issues. Further, in their conclusion: “In this evaluation, CBD appears to be better tolerated than routine psychiatric medications.” 

Clinical Trial: “Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report”

Published in: The Permanente Journal (2016)

This case report delved into the impact of CBD on pediatric anxiety and insomnia related to posttraumatic stress disorder (PTSD). The findings suggested that CBD oil might be a valuable addition to the treatment regimen for pediatric anxiety and sleep disturbances associated with PTSD.

Clinical Trial: “Cannabidiol in Anxiety and Sleep: A Large Case Series”

Published in: The Permanente Journal (2019)

The trial presented a large case series exploring the impact of CBD on anxiety and sleep. The results suggested that CBD not only reduced anxiety scores but also improved sleep in a majority of the subjects, indicating a potential dual benefit.

Happy and Healthy at the beach

Pain Management – CBD as the Compassionate Healer

Dreaming of a world where chronic pain doesn’t haunt you from day to day? This, too, can become a reality. Many Clinical trials suggest that CBD may in fact be just the compound needed for managing chronic pain:

Clinical Trial: 

Published in: 


Clinical Trial: “Cannabidiol in Patients with Treatment-Resistant Epilepsy: An Open-Label Interventional Trial”

Published in: The Lancet Neurology (2016)

While primarily focused on epilepsy, this trial inadvertently revealed insights into CBD’s potential in pain management. The study concluded that CBD significantly reduced seizure frequency in patients, hinting at its broader application in mitigating neurological discomfort.

Neuroprotection – CBD and the Brain Ballet

In the realm of neuroprotection, CBD takes center stage as a potential guardian of brain health. Clinical trials, such as the one featured in the Journal of Alzheimer’s Disease in 2014, have explored CBD’s role in slowing down neurodegenerative processes. The conclusion? CBD may be the superhero the brain needs to fend off conditions like Alzheimer’s:

Clinical Trial: “Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice”

Published in: Journal of Alzheimer’s Disease (2014)

Conclusion: “This study is the first to demonstrate CBD’s ability to prevent the development of a social recognition deficit in AD transgenic mice. Our findings provide the first evidence that CBD may have potential as a preventative treatment for AD with a particular relevance for symptoms of social withdrawal and facial recognition.” 

Clinical Trial: “Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine”

Published in: Mediators of Inflammation (2015)

While primarily addressing acute hepatic toxicity and seizures induced by cocaine, this trial incidentally explored CBD’s neuroprotective properties. The study concluded that CBD demonstrated a protective effect against both hepatic and neurological damage induced by cocaine, shedding light on its potential neuroprotective role.

Inflammation – CBD’s Soothing Symphony

Imagine a world where inflammation is but a distant memory, too! Clinical trials, including a study published in Future Medicinal Chemistry in 2019, concluded that CBD could be a promising therapeutic agent for various inflammatory conditions.

Clinical Trial: “Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress”

Published in: Free Radical Biology and Medicine (2011)

Examining CBD’s role in mitigating inflammation-induced oxidative stress, this trial revealed promising outcomes. The researchers concluded that CBD possesses considerable potential as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress, implicating its use in conditions characterized by chronic inflammation.

Clinical Trial: “Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death”

Published in: Journal of Pharmacology and Experimental Therapeutics (2019)

Focused on cisplatin-induced nephrotoxicity, this trial explored CBD’s potential in mitigating inflammation and cell death. The findings suggested that CBD could attenuate nephrotoxicity by reducing oxidative/nitrosative stress and inflammation, highlighting its anti-inflammatory properties in a specific clinical context.

Epilepsy – CBD’s Triumph

In the epic battle against epilepsy, CBD emerges as a valiant warrior. CBD’s triumph over seizures is a victory worth celebrating! The landmark clinical trial published in the New England Journal of Medicine in 2018 found that CBD significantly reduced seizure frequency in patients with Dravet syndrome, a rare and severe form of epilepsy:

Clinical Trial: “Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome.”

Published in: New England Journal of Medicine” (2018)

Among children and adults with the Lennox–Gastaut syndrome, the addition of cannabidiol at a dose of 10 mg or 20 mg per kilogram per day to a conventional antiepileptic regimen resulted in greater reductions in the frequency of drop seizures than placebo. Adverse events with cannabidiol included elevated liver aminotransferase concentrations.

Clinical Trial: “Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial”

Published in: The Lancet Neurology (2016)

This trial indicated that CBD significantly reduced seizure frequency in patients with treatment-resistant epilepsy, suggesting potential broader applications in neurology

CBD LEO-HB® logo

How LEO-HB® Technology Helps

  • LEO-HB® is an eco-friendly, state-of-the-art, solid-solid technology that turns poorly soluble, bioactive ingredients with low bioavailability into free-flowing high performance powders that are instantly Cold Water Dispersible and/or Soluble.
  • Contrary to many other technologies, LEO-HB® is a 100% natural, clean-label process, only uses food-grade Non-GMO ingredients, NO solvents (NO P.E.G, NO Polysorbates,) and has no negative impact on the digestive tract.
  • Only Food-Grade, Non-GMO, Clean Label ingredients are used for every LEO-HB® ingredient:  natural carrier (vegan or non-vegan), selected bioactive extract, natural glycerin (NO artificial emulsifiers, NO excipients, NO solvents)
  • Final LEO-HB® ingredient powders:
    • Are Cold Water Dispersible (80% min. vs. 0% for the unprocessed raw material)
    • Offer maximum bioavailability from 3x to 20x+
    • Offer customizable particle size

Conclusion: The CBD Odyssey Continues

In the grand tapestry of health and wellness, CBD emerges as a versatile and promising thread, weaving its way through various conditions with the support of compelling clinical evidence. As the scientific community continues to unravel the mysteries of CBD, these studies represent just a fraction of the growing body of research on CBD’s effects in humans. Whether you’re navigating the realms of anxiety, pain, sleep disorders, neuroprotection, or inflammation, CBD stands as a fascinating ally, backed not just by anecdotal claims but by the rigor of scientific inquiry. The journey of CBD continues, and with each clinical trial, we edge closer to unlocking its full therapeutic potential.

For finding links to these studies as well as many others, come on over to visit our Clinical Studies page.  

You can also download our Product Brochure on CBD LEO-HB®.

We will keep adding on links to the ever growing list of studies on this fascinating compound, as researchers add proof to the growing number of conditions that are alleviated by CBD.